Virbac (OTC:VRBCF) Shares Down 11.2% – Should You Sell?

Virbac SA (OTC:VRBCFGet Free Report) shares fell 11.2% during mid-day trading on Thursday . The company traded as low as $339.23 and last traded at $339.23. 23 shares traded hands during mid-day trading, a decline of 77% from the average session volume of 100 shares. The stock had previously closed at $382.00.

Virbac Trading Down 11.2 %

The firm’s 50-day moving average is $378.50 and its 200-day moving average is $374.76.

Virbac Company Profile

(Get Free Report)

Virbac SA manufactures and sells a range of products and services for companion animals and farm animals in France, Europe, Latin America, North America, Asia, Pacific, and Africa and the Middle East. The company offers a range of vaccines, dental hygiene, reproduction, dermatology, parasiticides, diagnostic, antibiotics, and aquaculture products; and veterinary medicines for anesthesia, geriatrics, behavior, and injectable micronutrients, as well as petfood and electronic identification.

Further Reading

Receive News & Ratings for Virbac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Virbac and related companies with MarketBeat.com's FREE daily email newsletter.